Please assess the completion status of the following clinical trial:

Trial Title: Additive Effects of Pravastatin and Valsartan

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Hypertension and low-density lipoprotein cholesterol levels \>100~Exclusion Criteria:~* Overt liver disease Chronic renal failure Hypothyroidism Myopathy Uncontrolled diabetes Severe hypertension

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- pravastatin (Type: ACTIVE_COMPARATOR): None
- valsartan (Type: ACTIVE_COMPARATOR): None
- pravastatin combined with valsartan (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).